Eli Lilly acquired ICOS Corporation for $34 per share (approximately $2.3 billion), gaining full ownership of Cialis (tadalafil) which had been jointly marketed through the Lilly ICOS LLC joint venture since 2003. The initial offer of $32/share was raised after institutional shareholder pushback.